Within this section of the website, you will find patient information regarding our licensed products. These information sources include patient information leaflets, the summary of product characteristics and European Public Assessment Reports.
- The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and provides important information about taking our licensed products.
- The summary of product characteristics (SmPC) is a description of a medicinal product including recommendations for its use.
- The European Public Assessment Report (EPAR) explains how the European Medicines Agency (EMA) assessed the medicine to recommend its authorisation in the EU and its conditions of use.
Please note that this information is specific to the UK and is not intended to replace the advice of a qualified doctor or pharmacist.